Utah laboratory gets FDA COVID-19 test approval, all set to produce 50K each day

SALT LAKE CITY– Following a rule change set up by the U.S. Food and Drug Administration Tuesday night, Utah molecular diagnostics business Co-Diagnostics has actually been cleared to distribute its COVID-19 test.

The business is prepared to produce 50,000 tests each day from its Salt Lake City laboratory and has the capability to make an additional 100,000 tests per day from another facility in India. The number of these tests may be provided for Utah patients was not instantly clear, though a company spokesman said earlier today that its capacity could “supply all of the screening needs in Utah and around us easily.”

The FDA changes that greenlighted circulation of the test will enable the company to “aggressively expand its presence in the U.S. market,” according to a news release.

Co-Diagnostics had previously made approval for its test from European health authorities and its test is currently in usage in Italy, Germany, the UK, Turkey, Greece, the Philippines, Thailand, Australia, Paraguay, Ecuador, Israel, South Africa and Canada, in addition to many deliveries to consumers and research study institutions in the United States.

The company said U.S. shipments to date have actually been in accordance with the FDA’s policy modification on Feb. 29 that allows qualified U.S. labs to utilize the Co-Diagnostics COVID-19 test under specific conditions. Now, as a result of the modification announced Tuesday night by the FDA, the business’s test set will quickly be available for usage by and marketed to a broad variety of U.S. laboratories, without very first requiring Emergency Usage Permission.

Co-Diagnostics CEO Dwight Egan stated the guideline modification puts his business in a position to have favorable impacts on the crucial requirement for COVID-19 testing capability in Utah, the U.S. and around the globe.

” The implications of this brand-new FDA policy are substantial for our business, Egan stated in a statement. “This change will rapidly manage Co-Diagnostics much more opportunities to serve the needs of laboratories nationwide, as we play an even larger function in responding to this pandemic.

” We praise the FDA’s decision to acknowledge the dire requirement for increased access to top quality COVID-19 tests, and to adjust as the scenario requires because of a public health emergency situation.”

This story will be updated as new info appears.

Correction: An earlier version explained the FDA decision as an approval, but a Co-Diagnostics representative clarified that the permission to distribute its COVID-19 test in the U.S. came via a rule change, not an official approval under the FDA’s emergency situation use guidelines.

%.

source https://jobsearchtips.net/utah-laboratory-gets-fda-covid-19-test-approval-all-set-to-produce-50k-each-day/